Dr Reddy’s Takes Another Step Forward On Tocilizumab

IV Version Of Indian Firm’s Actemra/RoActemra Biosimilar Completes Phase I Study

 
• By David Wallace
  
Clinical Trial Icon
Dr Reddy’s has completed another trial for its tocilizumab candidate • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products